Novel Procedures for Validating Surrogate Endpoints in Clinical Trials

By  

Current Clinical Pharmacology, Vol. 2, Iss. 2, 2007-05 ,pp. : 123-128

Bentham Science Publishers

Access to resources Recommend Favorite

Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials

By Hung H. M. James  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1201-1210

Taylor & Francis Ltd

Access to resources Recommend Favorite

Bivariate or Composite Plots of Endpoints

By Peace Karl  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 2, 2009-03 ,pp. : 324-331

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination in Superiority Clinical Trials with Multiple Co-Primary Correlated Endpoints

By Sozu Takashi  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 650-668

Taylor & Francis Ltd

Access to resources Recommend Favorite

Intermediate clinical endpoints: A bridge between progression-free survival and overall survival in ovarian cancer trials

By Matulonis Ursula A.   Oza Amit M.   Ho Tony W.   Ledermann Jonathan A.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1737-1746

Blackwell Publishing

Access to resources Recommend Favorite